Trajectories of systemic agent use and associated depression and anxiety-related healthcare costs among patients with psoriasis

Supplement materials, tables and figures for the research article "Trajectories of systemic agent use and associated depression and anxiety-related healthcare costs among patients with psoriasis".

Contributors: Raymond Milan, BSc, MSc; Jacques LeLorier, MD, PhD; Eric A Latimer, PhD; Marie-Josée Brouillette, MD; Anne Holbrook, MD, PharmD, MSc; Ivan V Litvinov, MD, PhD; Elham Rahme, PhD

Supplement material 1: Depression and anxiety-related healthcare costs
Supplement Table 1: International classification of diseases (ICD) 9th and 10th edition
Supplement Table 2: sensitivity analysis with 5 exposure groups
Supplement Table 3: sensitivity analysis excluding the costs of depression- and anxiety- related hospitalizations and ED visits
Supplement Figure 1: Study flowchart
Supplement Figure 2: Determining the optimal number of clusters